Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Use BioMicro's MAUI Array System With NCode miRNA Platform

NEW YORK (GenomeWeb News) – Invitrogen will use BioMicro Systems’ microarray user interface hybridization system with its new NCode miRNA profiling platform, the companies said last week.
 
The companies will co-market BioMicro’s system, called MAUI, with the NCode arrays. 
 
Invitrogen said “preliminary data” shows that using the MAUI system with the NCode arrays results in a 10-fold gain in sensitivity over manual hybridization.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.